Highlighting the critical role of Caris GPSai in improving cancer care. IRVING, Texas, March 20, 2026 /PRNewswire/ -- Caris ...
Researchers show that obesity alters pancreatic cells to produce cholecystokinin, which drives cancer growth, revealing new ...
Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...
This biological process, where mature, specialized cells lose their distinct characteristics and revert to a more primitive, aggressive state, is a universally recognized sign of poor prognosis across ...
Genome and epigenome editors—including CRISPR nucleases, base editors, prime editors, and emerging RNA/epitranscriptomic editors—are advancing rapidly, but ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.
Single-cell RNA sequencing of endometrial samples across the menstrual cycle identified key cell types and gene signatures ...
Singapore Business Review on MSN
Lucence, DXD Hub, and NCCS launch $6m UNITED 2.0 cancer test
The team will adopt a dual WES-WTS approach for more detailed tumour profiling. Lucence, Diagnostics Development Hub hosted ...
The three-year UNITED 2.0 initiative will use advanced DNA testing and AI to give doctors a more complete picture of a patient’s cancer and help match treatments more precisely.
Researchers identify five specific neuron subgroups in the motor cortex most vulnerable to TDP-43 protein clumps in ALS and Frontotemporal Dementia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results